# Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional

Source: https://welltoldgrants.com/grants/rfa-fd-24-029-collaborations-to-enhance-drug-development-and-regulatory/  
Official notice: https://www.grants.gov/search-results-detail/351691

> Food and Drug Administration offered grants of up to $5.0 million to colleges and universities. It expected to make about 6 awards worth $5.0 million in total. Applications closed on April 2, 2024.

| Field | Value |
|---|---|
| Opportunity number | RFA-FD-24-029 |
| Agency | Food and Drug Administration |
| Status | Forecast |
| Deadline | April 2, 2024 |
| Award ceiling | $5.0 million |
| Award floor | not stated |
| Expected awards | 6 |
| Total funding | $5.0 million |
| Cost sharing | not required |
| Assistance Listings | 93.103 |

## Who can apply

- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

(1) The entity is- (A) an institution of higher education (as such term is defined in section 1001 of title 20) or a consortium of such institutions; or (B) an organization described in section 501(c)(3) of title 26 and exempt from tax under section 501(a) of such title.(2) The entity has experienced personnel and clinical and other technical expertise in the biomedical sciences, which may include graduate training programs in areas relevant to priorities of the Critical Path Initiative.(3) The entity demonstrates they are capable of- (A) developing and critically evaluating tools, methods, and processes- (i) to increase efficiency, predictability, and productivity or medical product development; and (ii)to more accurately identify the benefits and risks of new and existing medical products (B) establishing partnerships and collaborations with health care practitioners and other providers of health care goods or services; pharmacists; pharmacy benefit managers and purchasers; health maintenance organizations and other managed health care organizations; health care insurers; government agencies; patients and consumers; manufacturers of prescription drugs, biological products, diagnostic technologies, and devices; and academic scientists; and (C) securing funding for the projects of a Critical Path Public-Private Partnership from Federal and nonfederal governmental sources, foundations, and private individuals.

## What the grant funds

This Notice of Funding Opportunity (NOFO) invites applications for a cooperative agreement to support, manage and facilitate Public-Private Partnerships and Collaborative activities as part of the Critical Path Initiative and to support regulatory science efforts. FDA and grantees will work together to develop innovative, collaborative projects in research, education, and outreach. These projects can help foster drug product innovation to 1) support efforts to accelerate drug product development; 2) support approaches to advanced manufacturing; 3) facilitate translation of basic science discoveries into therapeutics; and 4) facilitate approaches to enhance the safety, efficacy, quality, and performance of drug products. Projects are identified by FDA. Multiple awards may be funded under this NOFO and are directly dependent on drug development priorities and subject to the availability of funding.

## Questions people ask

### Is RFA-FD-24-029 still open?

No. It closed on April 2, 2024. A newer notice is open: PAR-27-017, rolling or no fixed deadline.

### Who can apply for Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional?

Food and Drug Administration accepted applications from colleges and universities. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional?

Closed April 2, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $5.0 million each. About $5.0 million in total across about 6 awards.

### Who has won Food and Drug Administration Research grants before?

The largest recipients over five fiscal years were The Critical Path Institute, National Environmental Health Association, Association of Food & Drug Officials. The program made 940 awards worth $1.2 billion in that time.